Jeff Kindler is an Operating Partner at Artis Ventures. He is currently the CEO of Centrexion Therapeutics. Previously, he was the CEO of Pfizer for 4 years where he led Pfizer’s $68 billion merger and acquisition of Wyeth. Prior to Pfizer, he served as the General Counsel for McDonalds.
As an Operating Partner, Jeff brings years of pharma leadership and management experience to the Artis Portfolio.